CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

In a report released yesterday, Lance Wilkes from Bernstein maintained a Hold rating on CVS Health, with a price target of $72.00. The company’s shares closed yesterday at $63.80. Wilkes covers the ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...

NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

The luxury group's jewelry division, which houses heavyweight brands Cartier and Van Cleef & Arpels, saw an 11% rise in sales. The Jeep parent said it would discontinue its hydrogen fuel-cell ...

Renault slashed its financial targets for the year, citing a worsening automotive market as the group faces stiff competition from rivals, and elevated finance chief Duncan Minto to interim CEO. J.B.